These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7496637)

  • 1. In vivo magnetic resonance spectroscopy. Applications in psychiatry.
    Maier M
    Br J Psychiatry; 1995 Sep; 167(3):299-306. PubMed ID: 7496637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging and spectroscopy in schizophrenia.
    Waddington JL; O'Callaghan E; Larkin C; Redmond O; Stack J; Ennis JT
    Br J Psychiatry Suppl; 1990; (9):56-65. PubMed ID: 2291820
    [No Abstract]   [Full Text] [Related]  

  • 3. Frontal lobe metabolism and cerebral morphology in schizophrenia: 31P MRS and MRI studies.
    Keshavan MS; Sanders RD; Pettegrew JW; Dombrowsky SM; Panchalingam KS
    Schizophr Res; 1993 Oct; 10(3):241-6. PubMed ID: 8260442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 31phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia.
    Deicken RF; Calabrese G; Merrin EL; Meyerhoff DJ; Dillon WP; Weiner MW; Fein G
    Biol Psychiatry; 1994 Oct; 36(8):503-10. PubMed ID: 7827212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia.
    Kato T; Shioiri T; Murashita J; Hamakawa H; Inubushi T; Takahashi S
    Psychiatry Res; 1995 Sep; 61(3):151-60. PubMed ID: 8545499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging.
    Fujimoto T; Nakano T; Takano T; Hokazono Y; Asakura T; Tsuji T
    Acta Psychiatr Scand; 1992 Dec; 86(6):455-62. PubMed ID: 1471539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia.
    Calabrese G; Deicken RF; Fein G; Merrin EL; Schoenfeld F; Weiner MW
    Biol Psychiatry; 1992 Jul; 32(1):26-32. PubMed ID: 1391294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance spectroscopy and its applications in psychiatry.
    Malhi GS; Valenzuela M; Wen W; Sachdev P
    Aust N Z J Psychiatry; 2002 Feb; 36(1):31-43. PubMed ID: 11929436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia.
    Pettegrew JW; Keshavan MS; Minshew NJ
    Schizophr Bull; 1993; 19(1):35-53. PubMed ID: 8451612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance spectroscopy and schizophrenia: what have we learnt?
    Vance AL; Velakoulis D; Maruff P; Wood SJ; Desmond P; Pantelis C
    Aust N Z J Psychiatry; 2000 Feb; 34(1):14-25. PubMed ID: 11185927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetry of temporal lobe phosphorous metabolism in schizophrenia: a 31phosphorous magnetic resonance spectroscopic imaging study.
    Deicken RF; Calabrese G; Merrin EL; Vinogradov S; Fein G; Weiner MW
    Biol Psychiatry; 1995 Sep; 38(5):279-86. PubMed ID: 7495921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
    Théberge J; Al-Semaan Y; Drost DJ; Malla AK; Neufeld RW; Bartha R; Manchanda R; Menon R; Densmore M; Schaefer B; Williamson PC
    Psychiatry Res; 2004 Jul; 131(2):107-14. PubMed ID: 15313517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial investigation of the left temporoparietal region in schizophrenia by 31P magnetic resonance spectroscopy.
    O'Callaghan E; Redmond O; Ennis R; Stack J; Kinsella A; Ennis JT; Larkin C; Waddington JL
    Biol Psychiatry; 1991 Jun; 29(11):1149-52. PubMed ID: 1873375
    [No Abstract]   [Full Text] [Related]  

  • 15. Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia.
    Hinsberger AD; Williamson PC; Carr TJ; Stanley JA; Drost DJ; Densmore M; MacFabe GC; Montemurro DG
    J Psychiatry Neurosci; 1997 Mar; 22(2):111-7. PubMed ID: 9074305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance and functional magnetic resonance imaging: tools for the study of human epilepsy.
    Kuzniecky R
    Curr Opin Neurol; 1997 Apr; 10(2):88-91. PubMed ID: 9146988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Resonance Spectroscopy for Psychiatry: Progress in the Last Decade.
    Port JD
    Neuroimaging Clin N Am; 2020 Feb; 30(1):25-33. PubMed ID: 31759569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heritability heightens brain metabolite differences in schizophrenia.
    Fukuzako H
    J Neuropsychiatry Clin Neurosci; 2000; 12(1):95-7. PubMed ID: 10678520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia.
    Deicken RF; Zhou L; Schuff N; Weiner MW
    Schizophr Res; 1997 Oct; 27(1):65-71. PubMed ID: 9373896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.